Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohty

Showing results (31-40 of 176) with videos related to

Pageof 18
Sort By:
European Journal of Haematology|November 4, 2004
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single centerG Damaj, M Mohty, N Vey, et al.
Leukemia|November 5, 2004
Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantationM Mohty, D Blaise, C Faucher, et al.
Annales De Dermatologie Et De Venereologie|September 6, 2005
[Granulomatous hypodermitis revealing a cutaneous mucormycosis in an immunodepressed patient]C Jouhet, A-M Mohty, A-M Taseï, et al.
Mucosal Immunology|July 9, 2015
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10B Lamarthée, F Malard, C Gamonet, et al.
Bone Marrow Transplantation|March 28, 2017
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvementJ A Snowden, E McGrath, R F Duarte, et al.
Leukemia|December 21, 2011
Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic reviewA Kumar, A R Mhaskar, T Reljic, et al.
Bone Marrow Transplantation|October 25, 2016
Inhibition of FLT3 in AML: a focus on sorafenibA Antar, Z K Otrock, J El-Cheikh, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Leukemia|April 22, 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparisonM Mohty, H de Lavallade, P Ladaique, et al.
Pageof 18

Showing results (31-40 of 176) with videos related to

Sort By:
Pageof 18
European Journal of Haematology|November 4, 2004
Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single centerG Damaj, M Mohty, N Vey, et al.
Leukemia|November 5, 2004
Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantationM Mohty, D Blaise, C Faucher, et al.
Annales De Dermatologie Et De Venereologie|September 6, 2005
[Granulomatous hypodermitis revealing a cutaneous mucormycosis in an immunodepressed patient]C Jouhet, A-M Mohty, A-M Taseï, et al.
Mucosal Immunology|July 9, 2015
Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10B Lamarthée, F Malard, C Gamonet, et al.
Bone Marrow Transplantation|March 28, 2017
JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvementJ A Snowden, E McGrath, R F Duarte, et al.
Leukemia|December 21, 2011
Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic reviewA Kumar, A R Mhaskar, T Reljic, et al.
Bone Marrow Transplantation|October 25, 2016
Inhibition of FLT3 in AML: a focus on sorafenibA Antar, Z K Otrock, J El-Cheikh, et al.
Bone Marrow Transplantation|November 21, 2012
Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie CellulaireS P Chantepie, M Mohty, R Tabrizi, et al.
Bone Marrow Transplantation|July 9, 2009
Prior treatment with gemtuzumab ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantationP Chevallier, T Prebet, P Turlure, et al.
Leukemia|April 22, 2005
The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparisonM Mohty, H de Lavallade, P Ladaique, et al.
Pageof 18